摘要
OBJECTIVE: To observe toxicity-reduced effects of Leigongteng(Radix et Rhizoma Tripterygii)(LGT) via compatibility with Jinqiancao(Herba Lysimachiae)(JQC) in H22-bearing mice and investigate the possible underlying mechanism, and further explore whether JQC can enhance LGT-evoked anti-tumor effect.METHODS: H22-bearing mice were orally administered with LGT alone and its compatibility with JQC, and tumors, serum, livers and kidneys were collected to evaluate the toxicity-reduced efficacy and the possible mechanism.RESULTS: LGT evoked significantly elevated biochemical indicators including serum alanine/aspartate transaminase(ALT/AST), creatinine(Cr) and urea nitrogen(BUN) as well as pathological damage in mice, which were all obviously reversed by JQC via compatibility at the ratios from 4/1 to 1/4.Further analysis indicated that pro-inflammatory cytokine tumor necrosis factor-alpha(TNF-α), and malondialdehyde(MDA) levels significantly decreased, while anti-inflammatory cytokine interleukin(IL)-10, and glutathione(GSH), GSH-s transferase(GST), GSH peroxidase(GSH-Px), superoxide dismutase(SOD) and catalase(CAT) levels all increased in livers and kidneys of mice. Besides, after compatibility with JQC at the ratios of 4/1, 2/1, 1/1,1/2 and 1/4, LGT-decreased tumor weight was further decreased by 48.4%, 57.3%, 54.0%, 49.3% and52.9%, respectively(all P < 0.01).CONCLUSION: JQC could reduce LGT-induced hepatotoxicity and nephrotoxicity, and enhance the antitumor efficacy via compatibility with JQC, and the toxicity-reduced mechanism could involve inhibiting hepatic and kidney oxidative stress and inflammation.
OBJECTIVE: To observe toxicity-reduced effects of Leigongteng(Radix et Rhizoma Tripterygii)(LGT) via compatibility with Jinqiancao(Herba Lysimachiae)(JQC) in H22-bearing mice and investigate the possible underlying mechanism, and further explore whether JQC can enhance LGT-evoked anti-tumor effect.METHODS: H22-bearing mice were orally administered with LGT alone and its compatibility with JQC, and tumors, serum, livers and kidneys were collected to evaluate the toxicity-reduced efficacy and the possible mechanism.RESULTS: LGT evoked significantly elevated biochemical indicators including serum alanine/aspartate transaminase(ALT/AST), creatinine(Cr) and urea nitrogen(BUN) as well as pathological damage in mice, which were all obviously reversed by JQC via compatibility at the ratios from 4/1 to 1/4.Further analysis indicated that pro-inflammatory cytokine tumor necrosis factor-alpha(TNF-α), and malondialdehyde(MDA) levels significantly decreased, while anti-inflammatory cytokine interleukin(IL)-10, and glutathione(GSH), GSH-s transferase(GST), GSH peroxidase(GSH-Px), superoxide dismutase(SOD) and catalase(CAT) levels all increased in livers and kidneys of mice. Besides, after compatibility with JQC at the ratios of 4/1, 2/1, 1/1,1/2 and 1/4, LGT-decreased tumor weight was further decreased by 48.4%, 57.3%, 54.0%, 49.3% and52.9%, respectively(all P < 0.01).CONCLUSION: JQC could reduce LGT-induced hepatotoxicity and nephrotoxicity, and enhance the antitumor efficacy via compatibility with JQC, and the toxicity-reduced mechanism could involve inhibiting hepatic and kidney oxidative stress and inflammation.
基金
Supported by the National Natural Science Foundation of China(No.81503269)
the Science and Technology Innovation Talent Fund of Henan Chinese Medicine(No.2015XCXRC01)
the Provincial Fundamental Research Fund in Henan University of Chinese Medicine(No.2014KYYWF-QN01)
